U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C21H28N2O
Molecular Weight 324.4598
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BIFEPRAMIDE

SMILES

CCN(CC)CCNC(=O)C(C)C1=CC=C(C=C1)C2=CC=CC=C2

InChI

InChIKey=GXLWOFJVIBEMCS-UHFFFAOYSA-N
InChI=1S/C21H28N2O/c1-4-23(5-2)16-15-22-21(24)17(3)18-11-13-20(14-12-18)19-9-7-6-8-10-19/h6-14,17H,4-5,15-16H2,1-3H3,(H,22,24)

HIDE SMILES / InChI
Molecular Formula C21H28N2O
Molecular Weight 324.4598
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Bifepramide, (+)- belong to the class of parasympatholytic agents that reduce the activity of the parasympathetic nervous system.

Approval Year

Unknown
149124
Patents

Patents

20100226943
186
6331289
128
Substance Class Chemical
Created
by admin
on Wed Apr 02 09:24:22 GMT 2025
Edited
by admin
on Wed Apr 02 09:24:22 GMT 2025
Record UNII
B1H2FS2WPP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BIFEPRAMIDE
INN  
INN  
Official Name English
bifepramide [INN]
Preferred Name English
(±)-N-(2-(DIETHYLAMINO)ETHYL)-.ALPHA.-METHYL-4-BIPHENYLACETAMIDE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C241
Created by admin on Wed Apr 02 09:24:22 GMT 2025 , Edited by admin on Wed Apr 02 09:24:22 GMT 2025
Code System Code Type Description
SMS_ID
100000085903
Created by admin on Wed Apr 02 09:24:22 GMT 2025 , Edited by admin on Wed Apr 02 09:24:22 GMT 2025
PRIMARY
PUBCHEM
68900
Created by admin on Wed Apr 02 09:24:22 GMT 2025 , Edited by admin on Wed Apr 02 09:24:22 GMT 2025
PRIMARY
ECHA (EC/EINECS)
275-076-3
Created by admin on Wed Apr 02 09:24:22 GMT 2025 , Edited by admin on Wed Apr 02 09:24:22 GMT 2025
PRIMARY
FDA UNII
B1H2FS2WPP
Created by admin on Wed Apr 02 09:24:22 GMT 2025 , Edited by admin on Wed Apr 02 09:24:22 GMT 2025
PRIMARY
CAS
70976-76-0
Created by admin on Wed Apr 02 09:24:22 GMT 2025 , Edited by admin on Wed Apr 02 09:24:22 GMT 2025
PRIMARY
EVMPD
SUB05828MIG
Created by admin on Wed Apr 02 09:24:22 GMT 2025 , Edited by admin on Wed Apr 02 09:24:22 GMT 2025
PRIMARY
ChEMBL
CHEMBL2107594
Created by admin on Wed Apr 02 09:24:22 GMT 2025 , Edited by admin on Wed Apr 02 09:24:22 GMT 2025
PRIMARY
EPA CompTox
DTXSID20867975
Created by admin on Wed Apr 02 09:24:22 GMT 2025 , Edited by admin on Wed Apr 02 09:24:22 GMT 2025
PRIMARY
INN
5204
Created by admin on Wed Apr 02 09:24:22 GMT 2025 , Edited by admin on Wed Apr 02 09:24:22 GMT 2025
PRIMARY
NCI_THESAURUS
C72110
Created by admin on Wed Apr 02 09:24:22 GMT 2025 , Edited by admin on Wed Apr 02 09:24:22 GMT 2025
PRIMARY
Related Record Type Details
Structure of BIFEPRAMIDE, (+)-
ENANTIOMER -> RACEMATE
Structure of BIFEPRAMIDE, (-)-
ENANTIOMER -> RACEMATE
Related Record Type Details
Structure of BIFEPRAMIDE
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966